Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06447454
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-06-03
Brief Title:
Combining Chemoradiotherapy With Sintilimab in First-Line ICC
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Organization Data
Organization:
Shanghai Zhongshan Hospital
Class:
OTHER
Study ID:
zs-ICC-RTGCHLX10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Zhongshan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None